The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke

BACKGROUND: Intravenous recombinant tissue plasminogen activator (rt-PA) is approved for use in selected patients with ischaemic stroke within 3 hours of symptom onset. IST-3 seeks to determine whether a wider range of patients may benefit. DESIGN: International, multi-centre, prospective, randomize...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Sandercock, Peter, Lindley, Richard, Wardlaw, Joanna, Dennis, Martin, Lewis, Steff, Venables, Graham, Kobayashi, Adam, Czlonkowska, Anna, Berge, Eivind, Slot, Karsten Bruins, Murray, Veronica, Peeters, Andre, Hankey, Graeme, Matz, Karl, Brainin, Michael, Ricci, Stefano, Celani, Maria Grazia, Righetti, Enrico, Cantisani, Teresa, Gubitz, Gord, Phillips, Steve, Arauz, Antonio, Prasad, Kameshwar, Correia, Manuel, Lyrer, Phillippe
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2008
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2442584/
https://ncbi.nlm.nih.gov/pubmed/18559104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-9-37
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky